Floatz logo

L-5-MTHF

Hyperhomocysteinemia

IRCCS Azienda Ospedaliero-Universitaria di BolognaSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Hyperhomocysteinemia cohort.

Asset / SponsorPhaseRating
Folic Acid
Shenzhen Ausa Pharmed Co.,Ltd
Phase 4BBB
Folic Acid
Fuling Central Hospital of Chongqing City
Phase 4BB
Enalapril Maleate
Fuling Central Hospital of Chongqing City
Phase 4BB
Folate
Universidade Estadual de Londrina
Phase 4BB
AMLODIPINE
Shenzhen Ausa Pharmed Co.,Ltd
Phase 4BB
Test 4
Center for Health Sciences, Serbia
Phase 3BB
Vitamin B6
Center for Health Sciences, Serbia
Phase 3BB
CYANOCOBALAMINUM
Georgetown University
N/AD

Same molecule, other indications

L-5-MTHF is also rated in:

homocystinuria due to methylene tetrahydrofolate reductase deficiencyDormant
BB
Indicative ·
65 / 100
View asset →
hypertensive disorderDormant
B
Indicative ·
62 / 100
View asset →
depressive disorderDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →